CME / ABIM MOC / CE Information

Accreditation Statements
PHYSICIANS: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of the Johns Hopkins University School of Medicine and the Postgraduate Institute of Medicine. The Johns Hopkins University School of Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Successful completion of this CME activity enables the participant to earn up to 3 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC points.

MOC Approval Statement
Through the American Board of Medical Specialties (“ABMS”) ongoing commitment to increase access to practice relevant Maintenance of Certification (“MOC”) Activities through the ABMS Continuing Certification Directory, Safe Means of Administering the Right Therapy Extended Release and Long Acting-Opioids - Get SMART ER/LA has met the requirements as an MOC Part II CME Activity (apply toward general CME requirement) and/or an MOC Part II Self-Assessment Activity for the following ABMS Member Boards:

MOC Part II CME Activity
Ophthalmology
Physical Medicine and Rehabilitation
MOC Part II SA
Anesthesiology
Allergy and Immunology
Colon and Rectal Surgery
Family Medicine
Orthopaedic Surgery
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology

Please note, MOC credit is reported on a monthly basis.

Credit Designations PHYSICIANS: The Johns Hopkins University School of Medicine designates this enduring activity for a maximum of 3.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity.

Joint Accreditation Statement

In support of improving patient care, this activity has been planned and implemented by the Postgraduate Institute for Medicine and DKBmed. Postgraduate Institute for Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Continuing Nursing Education

The maximum number of hours awarded for this Continuing Nursing Education activity is 2.5 contact hours. Designated for 1.0 contact hours of pharmacotherapy credit for Advance Practice Registered Nurses.

PIM Disclosure Information:

The PIM planners and managers, Trace Hutchison, PharmD, Samantha Mattiucci, PharmD, CHCP, Judi Smelker-Mitchek, MBA, MSN, RN, and Jan Schultz, MSN, RN, CHCP have nothing to disclose.

Original Release Date: November 30, 2015
Release Update: February 24, 2017
Expiration Date: February 23, 2018
New Release Date: January 11, 2018
New Expiration Date: January 31, 2020

Each module is estimated to take 30 minutes to complete.

Learning Objectives
After completing this activity, the participant will demonstrate the ability to:

  • Assess patients for treatment with ER/LA opioid analgesics.
  • Evaluate and initiate opioid therapy.
  • Modify dose and discontinue use of ER/LA opioid analgesics.
  • Manage ongoing therapy with ER/LA opioid analgesics.
  • Perform effective counseling with patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.
  • Identify general and product-specific drug information concerning ER/LA opioid analgesics.

COURSE DIRECTORS

Michael R. Clark, MD, MPH, MBA
Chair, Psychiatry & Behavior Health
Inova Health System
Falls Church, VA

Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP
Pain Management Nurse Practitioner
Ponte Vedra Beach, FL

POLICY ON SPEAKER AND PROVIDER DISCLOSURE
It is the policy of the Johns Hopkins University School of Medicine that the speaker and provider globally disclose conflicts of interest. The Johns Hopkins University School of Medicine OCME has established policies in place that will identify and resolve all conflicts of interest prior to this educational activity. Detailed disclosure will be made in the instructional materials.

FULL DISCLOSURE POLICY AFFECTING CME ACTIVITIES
As a provider approved by the Accreditation Council for Continuing Medical Education (ACCME), Johns Hopkins University School of Medicine Office of Continuing Medical Education (OCME) requires attested and signed global disclosure of the existence of all financial interests or relationships with commercial interest from any individual in a position to control the content of a CME activity sponsored by OCME. The following relationships have been reported for this activity:

Planners Relationship
Michael R. Clark, MD, MPH, MBA Consulting Fees: Collegium, Depomed, Endo
Yvonne D'Arcy, MS, ARNP-C, CNS, FAANP Honoraria: Eaglet, Ortho-McNeil
Editorial Support: Pfizer, Inc.
Royalty: Springer Publishing

No other planners have indicated that they have any financial interest or relationships with a commercial entity.

Note: Grants to investigators at The Johns University are negotiated and administrated by the institution which receives the grants, typically through the office of Research Administration. Individual investigators who participate in the sponsored projects are not directly compensated by the sponsor, but may receive other support from the institution to support their effort on the project(s).


Target Audience
The target audience to complete this program includes any allied health professionals whom will or have prescribed ER/LA opioid analgesics in the past 12 months.
There are no prerequisites.

Off-label Product Discussion
There will be no discussions of off-label or unapproved uses of drugs or products.

Statement of Responsibility
The Johns Hopkins University School of Medicine takes responsibility for the content, quality, and scientific integrity of this CME activity.

Statement of Need
Through a review of the current literature; detailed conversations with expert educators; and a survey of clinicians past program participants; the following core gaps have been identified:

  • Clinicians may not be properly assessing patients for treatment with ER/LA opioid analgesics
  • Clinicians may not be properly initiating therapy, modifying doses, and discontinuing use of ER/LA opioid analgesics
  • Clinicians may not employ best practices when managing ongoing therapy with ER/LA opioid analgesics
  • Clinicians have indicated a lack of awareness of general and product-specific drug information about ER/LA opioid analgesics
  • Clinicians may not be counseling patients and caregivers about the safe use of ER/LA opioid analgesics, including proper storage and disposal.

This educational activity is supported by an independent educational grant from ER/LA Opioid Analgesic REMS Program Companies.

HIPAA STATEMENT
CONFIDENTIALITY DISCLAIMER FOR CME ACTIVITY PARTICIPANTS
I certify that I am participating a Johns Hopkins University School of Medicine CME activity for accredited training and/or educational purposes.
I understand that while I am participating in this capacity, I may be exposed to "protected health information," as that term is defined and used in Hopkins policies and in the federal HIPAA privacy regulations (the "Privacy Regulations"). Protected health information is information about a person's health or treatment that identifies the person.
I pledge and agree to use and disclose any of this protected health information only for the training and/or educational purposes of my visit and to keep the information confidential. I agree not to post or discuss this protected health information, including pictures and/or videos, on any social media site (e.g. Facebook, Twitter, etc.), in any electronic messaging program or through any portable electronic device.
I understand that I may direct to the Johns Hopkins Privacy Officer any questions I have about my obligations under this Confidentiality Pledge or under any of the Hopkins policies and procedures and applicable laws and regulations related to confidentiality. The contact information is: Johns Hopkins Privacy Officer, telephone: 410-735-6509, e-mail: HIPAA@jhmi.edu.
"The Office of Continuing Medical Education at the Johns Hopkins University School of Medicine, as provider of this activity, has relayed information with the CME attendees/participants and certifies that the visitor is participating for training, education and/or observation purposes only."
For CME Questions, please contact the CME Office
(410) 955-2959 or e-mail cmenet@jhmi.edu.
For CME Certificates, please call (410) 502-9634.

Johns Hopkins University School of Medicine Office of Continuing Medical Education
Turner 20/720 Rutland Avenue
Baltimore, Maryland 21205-2195

Reviewed & Approved by:
General Counsel, Johns Hopkins Medicine (4/1/03)
(Updated 4/09 and 3/14)